Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price traded up 47.4% during trading on Friday . The stock traded as high as C$0.14 and last traded at C$0.14. 1,312,210 shares traded hands during mid-day trading, an increase of 427% from the average session volume of 249,010 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Stock Performance
The stock has a market capitalization of C$19.53 million, a PE ratio of -14.00 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The firm has a 50 day moving average of C$0.08 and a 200-day moving average of C$0.06.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- How to Invest in Small Cap Stocks
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- 3 Warren Buffett Stocks to Buy Now
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- 3 Small Caps With Big Return Potential
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
